Abstract
Historically, the prognosis of allogeneic hematopoietic stem cell transplant (allo-HCT) recipients who require intensive care unit (ICU) admission has been poor. We aimed to describe the epidemiological trends of ICU utilization and outcomes in allo-HCT patients. We conducted a retrospective cohort study including adults (≥ 18) undergoing allo-HCT between 01/01/2005 and 31/12/2020 at Mayo Clinic, Rochester. Temporal trends in outcomes were assessed by robust linear regression modelling. Risk factors for hospital mortality were chosen a priori and assessed with multivariable logistic regression modelling. Of 1,249 subjects, there were 486 ICU admissions among 287 individuals. Although older patients underwent allo-HCT (1.64 [95% CI: 1.11 to 2.45] years per year; P = 0.025), there was no change in ICU utilization over time (P = 0.91). The ICU and hospital mortality rates were 19.2% (55/287) and 28.2% (81/287), respectively. There was a decline in ICU mortality (-0.38% [95% CI: -0.70 to -0.06%] per year; P = 0.035). The 1-year post-HCT mortality for those requiring ICU admission was 56.1% (161/287), with no significant difference over time, versus 15.8% (141/891, 71 missing) among those who did not. The frequency and duration of invasive mechanical ventilation (IMV) declined. In multivariable analyses, higher serum lactate, higher sequential organ failure assessment (SOFA) scores, acute respiratory distress (ARDS), and need for IMV were associated with greater odds of hospital mortality. Over time, rates of ICU utilization have remained stable, despite increasing patient age. Several trends suggest improvement in outcomes, notably lower ICU mortality and frequency of IMV. However, long-term survival remains unchanged. Further work is needed to improve long-term outcomes in this population.
Similar content being viewed by others
Abbreviations
- Allo-HCT :
-
Allogeneic hematopoietic stem cell transplant
- AKI :
-
Acute kidney injury
- APACHE :
-
Acute physiology and chronic health evaluation
- ARDS :
-
Acute respiratory distress syndrome
- AST :
-
Aspartate transaminase
- CI :
-
Confidence interval
- FEV 1 :
-
Forced expiratory volume in 1 s
- GVHD :
-
Graft-versus-host disease
- HCT-CI :
-
Hematopoietic Cell Transplantation (HCT)-specific Comorbidity Index
- ICU :
-
Intensive care unit
- IMV :
-
Invasive mechanical ventilation
- IQR :
-
Interquartile range
- LVEF :
-
Left ventricular ejection fraction
- OR :
-
Odds ratio
- SOFA :
-
Sequential organ failure assessment
References
Gooley TA, Chien JW, Pergam SA et al (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363:2091–2101. https://doi.org/10.1056/NEJMoa1004383
McDonald GB, Sandmaier BM, Mielcarek M et al (2020) Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003–2007 Versus 2013–2017 Cohorts. Ann Intern Med 172:229–239. https://doi.org/10.7326/M19-2936
Penack O, Peczynski C, Mohty M et al (2020) How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT. Blood Adv 4:6283–6290. https://doi.org/10.1182/bloodadvances.2020003418
Lilly CM, Swami S, Liu X et al (2017) Five-year trends of critical care practice and outcomes. Chest 152:723–735. https://doi.org/10.1016/j.chest.2017.06.050
Danziger J, Armengol Á, de la Hoz M, Li W et al (2020) Temporal trends in critical care outcomes in U.S. minority-serving hospitals. Am J Respir Crit Care Med 201:681–687. https://doi.org/10.1164/rccm.201903-0623OC
Zimmerman JE, Kramer AA, Knaus WA (2013) Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012. Crit Care 17:R81. https://doi.org/10.1186/cc12695
Evans L, Rhodes A, Alhazzani W et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47:1181–1247. https://doi.org/10.1007/s00134-021-06506-y
Network ARDS, Brower RG, Matthay MA et al (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308. https://doi.org/10.1056/NEJM200005043421801
Li G, Malinchoc M, Cartin-Ceba R et al (2011) Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med 183:59–66. https://doi.org/10.1164/rccm.201003-0436OC
Rubenfeld GD, Crawford SW (1996) Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med 125:625–633. https://doi.org/10.7326/0003-4819-125-8-199610150-00001
Pène F, Aubron C, Azoulay E et al (2006) Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 24:643–649. https://doi.org/10.1200/JCO.2005.03.9073
Darmon M, Bourmaud A, Georges Q et al (2019) Changes in critically ill cancer patients’ short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. Intensive Care Med 45:977–987. https://doi.org/10.1007/s00134-019-05653-7
(2019) Donation and transplantation statistics. In: Blood Stem Cell. https://bloodstemcell.hrsa.gov/data/donation-and-transplantation-statistics. Accessed 2 Apr 2023
von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147:573–577. https://doi.org/10.7326/0003-4819-147-8-200710160-00010
Kashyap R, Sarvottam K, Wilson GA et al (2020) Derivation and validation of a computable phenotype for acute decompensated heart failure in hospitalized patients. BMC Med Inform Decis Mak 20:85. https://doi.org/10.1186/s12911-020-1092-5
Herasevich V, Pickering BW, Dong Y et al (2010) Informatics infrastructure for syndrome surveillance, decision support, reporting, and modeling of critical illness. Mayo Clin Proc 85:247–254. https://doi.org/10.4065/mcp.2009.0479
Definition Task Force ARDS, Ranieri VM, Rubenfeld GD et al (2012) Acute respiratory distress syndrome: the Berlin Definition. JAMA 307:2526–2533. https://doi.org/10.1001/jama.2012.5669
Ostermann M, Joannidis M (2016) Acute kidney injury 2016: diagnosis and diagnostic workup. Crit Care 20:299. https://doi.org/10.1186/s13054-016-1478-z
Hoaglin DC, Mosteller F, Tukey JW (2011) Exploring data tables, trends, and shapes. John Wiley & Sons
Herasevich S, Frank RD, Bo H et al (2021) Pretransplant risk factors can predict development of acute respiratory distress syndrome after hematopoietic stem cell transplantation. Ann Am Thorac Soc 18:1004–1012. https://doi.org/10.1513/AnnalsATS.202004-336OC
Herasevich S, Frank RD, Hogan WJ et al (2023) Post-Transplant and in-hospital risk factors for ARDS after hematopoietic stem cell transplantation. Respir Care 68:77–86. https://doi.org/10.4187/respcare.10224
Lederer DJ, Bell SC, Branson RD et al (2019) Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals. Ann Am Thorac Soc 16:22–28. https://doi.org/10.1513/AnnalsATS.201808-564PS
Ripley BD (2001) The R project in statistical computing. MSOR Connect 1(1):23–25. https://doi.org/10.11120/msor.2001.01010023
MASS citation info. https://cran.r-project.org/web/packages/MASS/citation.html. Accessed 19 Apr 2023
Saillard C, Darmon M, Bisbal M et al (2018) Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality. Bone Marrow Transplant 53:1233–1241. https://doi.org/10.1038/s41409-018-0181-x
Lueck C, Stadler M, Koenecke C et al (2018) Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intensive Care Med 44:1483–1492. https://doi.org/10.1007/s00134-018-5347-x
Garcia Borrega J, Heger J-M, Koehler P et al (2022) Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes-results of a retrospective analysis from a German university hospital. Ann Hematol 101:389–395. https://doi.org/10.1007/s00277-021-04698-3
Mayer S, Pastores SM, Riedel E et al (2017) Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period. Leuk Lymphoma 58:382–390. https://doi.org/10.1080/10428194.2016.1195499
Michel CS, Teschner D, Schmidtmann I et al (2019) Prognostic factors and outcome of adult allogeneic hematopoietic stem cell transplantation patients admitted to intensive care unit during transplant hospitalization. Sci Rep 9:19911. https://doi.org/10.1038/s41598-019-56322-0
Gournay V, Dumas G, Lavillegrand J-R et al (2021) Outcome of allogeneic hematopoietic stem cell transplant recipients admitted to the intensive care unit with a focus on haploidentical graft and sequential conditioning regimen: results of a retrospective study. Ann Hematol 100:2787–2797. https://doi.org/10.1007/s00277-021-04640-7
Mokart D, Granata A, Crocchiolo R et al (2015) Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit. J Crit Care 30:1107–1113. https://doi.org/10.1016/j.jcrc.2015.06.020
Bazarbachi A, Schmid C, Labopin M et al (2020) Evaluation of trends and prognosis over time in patients with AML relapsing after allogeneic hematopoietic cell transplant reveals improved survival for young patients in recent years. Clin Cancer Res 26:6475–6482. https://doi.org/10.1158/1078-0432.CCR-20-3134
Platon L, Amigues L, Ceballos P et al (2016) A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009–2013). Bone Marrow Transplant 51:256–261. https://doi.org/10.1038/bmt.2015.269
Benz R, Schanz U, Maggiorini M et al (2014) Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transplant 49:62–65. https://doi.org/10.1038/bmt.2013.141
Lindgaard SC, Nielsen J, Lindmark A, Sengeløv H (2016) Prognosis of allogeneic haematopoietic stem cell recipients admitted to the intensive care unit: a retrospective, single-centre study. Acta Haematol 135:72–78. https://doi.org/10.1159/000440937
Bayraktar UD, Shpall EJ, Liu P et al (2013) Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol 31:4207–4214. https://doi.org/10.1200/JCO.2013.50.5867
Townsend WM, Holroyd A, Pearce R et al (2013) Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. Br J Haematol 161:578–586. https://doi.org/10.1111/bjh.12294
Archanjo LVF, Caruso P, Nassar Junior AP (2022) One-year mortality of hematopoietic stem cell recipients admitted to an intensive care unit in a dedicated Brazilian cancer center: a retrospective cohort study. Sao Paulo Med J 141:107–113. https://doi.org/10.1590/1516-3180.2021.0986.R1.11052022
Neuschwander A, Lemiale V, Darmon M et al (2017) Noninvasive ventilation during acute respiratory distress syndrome in patients with cancer: Trends in use and outcome. J Crit Care 38:295–299. https://doi.org/10.1016/j.jcrc.2016.11.042
Papazian L, Corley A, Hess D et al (2016) Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review. Intensive Care Med 42:1336–1349. https://doi.org/10.1007/s00134-016-4277-8
Bellani G, Laffey JG, Pham T et al (2016) Epidemiology, Patterns of Care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315:788–800. https://doi.org/10.1001/jama.2016.0291
Acknowledgements
Hemang Yadav and Kiyan Heybati contributed to the study conception and design. Data retrieval was done by Hemang Yadav and Domenic Ochal, and Svetlana Herasevich. Data analysis and table and figure preparation were performed by Kiyan Heybati, Domenic Ochal, and Hemang Yadav. The first draft of the manuscript was written by Kiyan Heybati. All authors contributed to the interpretation of the data and critically appraised the manuscript All authors commented on previous versions of the manuscript and read and approved the final manuscript. Hemang Yadav serves as the corresponding author and guarantor for the work.
Funding
This project was supported by Grant Number K23HL151671 (Recipient: Hemang Yadav) from the National Heart, Lung, and Blood Institute of the National Institute of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None of the authors declare any conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Heybati, K., Ochal, D., Hogan, W. et al. Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients. Ann Hematol 103, 957–967 (2024). https://doi.org/10.1007/s00277-023-05612-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-023-05612-9